The hormone most directly responsible for skin pigmentation is alpha-melanocyte-stimulating hormone, commonly called alpha-MSH. It binds to receptors on melanocytes (the cells that produce pigment) and triggers them to make melanin, the compound that gives skin its color. But alpha-MSH isn’t the only player. Estrogen, progesterone, insulin, thyroid hormones, and stress hormones all influence how much pigment your skin produces, sometimes in ways that create visible dark patches or overall changes in skin tone.
How Alpha-MSH Drives Pigment Production
Alpha-MSH is the master switch for melanin synthesis. When it locks onto a receptor called MC1R on the surface of a melanocyte, it sets off a chain reaction inside the cell. The cell ramps up production of tyrosinase, the key enzyme that converts the amino acid tyrosine into melanin. Alpha-MSH also activates transcription factors that keep this pigment-production machinery running, so the effect isn’t just a brief burst. It sustains melanin output over time.
Beyond simply making more pigment, alpha-MSH determines the type of melanin produced. Human skin makes two kinds: eumelanin (brown-black pigment that provides stronger UV protection) and pheomelanin (a reddish-yellow pigment). Alpha-MSH shifts the balance toward eumelanin, which is why tanning produces a brown tone rather than a reddish one.
Why Sun Exposure Amplifies the Effect
Sunlight doesn’t just darken existing melanin. UVB radiation damages DNA in keratinocytes (the cells that make up most of the skin’s outer layer), which triggers a protective response. Those damaged cells activate the gene for a precursor molecule called POMC, which gets chopped into several smaller hormones, including alpha-MSH and ACTH. The freshly released alpha-MSH then signals nearby melanocytes to start producing more pigment. This is the delayed tanning response, the gradual darkening that develops over days after sun exposure.
This UV-triggered hormonal cascade is one reason hormonal pigmentation problems tend to worsen with sun exposure. If your melanocytes are already being stimulated by estrogen or other hormones, the added alpha-MSH from UV exposure stacks on top, making dark patches noticeably darker.
Estrogen, Progesterone, and Melasma
Estrogen and progesterone are the hormones behind melasma, the patchy brown or gray-brown discoloration that commonly appears on the face during pregnancy or while taking hormonal contraceptives. Globally, melasma affects roughly 1 to 2% of people in Western countries, but prevalence climbs sharply in certain populations: up to 15 to 35% of Brazilian women, nearly 40% of Iranian women, and 41% of Indian agricultural workers exposed to heavy sunlight.
Estrogen stimulates melanocytes through multiple routes. The most potent natural form, estradiol, binds to receptors on melanocytes and directly turns up the genes for tyrosinase and related enzymes. It also activates a fast-acting membrane receptor that rapidly boosts the same signaling molecules alpha-MSH uses, essentially doubling down on pigment production. During pregnancy, a weaker form of estrogen called estriol rises to high levels and promotes oxidative stress in skin cells, which itself triggers additional melanin synthesis.
Progesterone adds fuel by activating yet another signaling pathway that increases tyrosinase and related enzyme production. The combination of elevated estrogen and progesterone during pregnancy is why up to 70% of pregnant women notice some degree of skin darkening, particularly on the face, nipples, and a line down the abdomen called the linea nigra.
People with darker skin tones (Fitzpatrick types IV through VI) face a harder time clearing melasma once it develops. Studies show relapse-free rates of only about 45% in darker-skinned individuals compared to 63% in lighter skin types.
ACTH and Adrenal Conditions
Adrenocorticotropic hormone, or ACTH, comes from the same precursor molecule as alpha-MSH and can activate the same MC1R receptor on melanocytes. Under normal conditions, ACTH levels stay low enough that it doesn’t noticeably affect skin color. But in Addison’s disease (primary adrenal insufficiency), the adrenal glands stop producing enough cortisol. The brain responds by flooding the body with the precursor molecule POMC in an attempt to stimulate the adrenals, and alpha-MSH gets released as a byproduct.
The result is a distinctive bronze hyperpigmentation, often most visible on skin creases, gums, scars, and areas exposed to friction like the knuckles and elbows. This darkening is sometimes the first visible clue that leads to an Addison’s diagnosis.
Cortisol and Stress-Related Changes
While ACTH increases pigmentation, cortisol (the hormone ACTH is trying to stimulate) does the opposite. Research in animal models shows that chronic stress and sustained high cortisol levels suppress melanin production. Mice exposed to chronic stress developed visibly lighter skin within about two weeks, and mice given direct cortisol injections showed the same lightening effect.
The mechanism appears to be indirect. Cortisol suppresses the skin’s own local hormone-signaling system, reducing the expression of the very molecules (including local alpha-MSH) that keep melanocytes active. When researchers blocked cortisol’s receptor in stressed mice, skin color darkened again. This finding raises the possibility that chronic stress could contribute to uneven skin tone or conditions involving pigment loss, though human studies are still limited.
Insulin and Dark Skin Patches
Insulin doesn’t affect melanocytes the same way alpha-MSH or estrogen does, but high insulin levels create a distinct type of skin darkening called acanthosis nigricans. These are velvety, darkened patches that typically appear on the neck, armpits, and groin. The darkening happens because excess circulating insulin activates growth factor receptors on skin cells, causing them to multiply rapidly. The thickened skin traps more melanin, and biopsies show both increased keratinocyte growth and melanocyte proliferation.
Acanthosis nigricans is strongly associated with insulin resistance and type 2 diabetes. The patches themselves aren’t harmful, but they’re a visible signal that insulin levels are chronically elevated and metabolic health may need attention.
Thyroid Hormones
Both overactive and underactive thyroid function can alter skin pigmentation, though it’s more commonly reported with hyperthyroidism. In hypothyroidism, the connection is less well established but documented. One case described a 42-year-old woman with subclinical hypothyroidism who developed scattered dark patches on her neck, armpits, arms, and chest. Biopsy showed increased pigment deposits in the deepest layer of the epidermis. Her hyperpigmentation improved after thyroid hormone levels were corrected with treatment.
Managing Hormonal Pigmentation
Because hormonal pigmentation involves melanocytes that are being actively stimulated from within, it tends to be stubborn. The most widely used topical treatment is hydroquinone, which works by inhibiting tyrosinase, the same enzyme that alpha-MSH activates. Concentrations of 2 to 4% are standard, and visible improvement typically takes five to seven weeks of daily application, with treatment continuing for at least three months and sometimes up to a year.
Sunscreen is non-negotiable for anyone dealing with hormonal pigmentation. In one study, combining 3% hydroquinone with daily sunscreen produced a 96% improvement in melasma appearance, compared to 81% with hydroquinone alone. This makes sense given that UV exposure generates its own burst of alpha-MSH, which would counteract any treatment aimed at reducing pigment.
Alternatives like kojic acid (typically at 0.75%) and thiamidol (at 0.2%) have shown effectiveness for people who can’t tolerate hydroquinone. Addressing the underlying hormonal driver, whether that means adjusting contraceptives, treating thyroid dysfunction, or improving insulin sensitivity, is often the most effective long-term strategy for preventing recurrence.